PMID: 6398024Jan 1, 1984Paper

The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis

Annals of the New York Academy of Sciences
W W TourtellotteP Shapshak

Abstract

The status of the central nervous system as an immunologic organ synthesizing IgG in several neurological diseases has been established convincingly in the past two decades. The measurement of intra-BBB IgG synthesis has been accomplished. It has been demonstrated that this synthesis is a potential marker for an abnormal immunologic process within the CNS which if manipulated may be a quantifiable aspect of disease modulation. Modulation of intra-BBB IgG synthesis is feasible, but there is no evidence yet that modulation of this synthesis is an index of effective disease control in MS. Only ACTH and corticosteroids lead to a significant and lasting depression of intra-BBB IgG synthesis, even though clonal eradication is not achieved. Based on our immunopharmacologic studies in MS we have proposed an immunokinetic model. The qualitative analysis of the specificity of IgG synthesized intra-BBB in MS has not led to the etiology of MS, but utilization of quantitative methods may. Questions raised by this review with suggested experiments to advance further our understanding of intra-BBB IgG synthesis as it relates to the etiopathogenesis of MS are included.

References

Jan 1, 1977·British Medical Bulletin·C W Adams
Oct 13, 1966·The New England Journal of Medicine·C A Janeway, F S Rosen
Dec 1, 1968·Journal of Molecular Biology·D SchubertS Ohno
Dec 1, 1968·Journal of Molecular Biology·D Schubert, M Cohn
Oct 1, 1980·Archives of Neurology·W W TourtellotteZ Petrovich
Jul 1, 1984·Neurology·W J WeinerR H Glantz
Sep 1, 1983·Archives of Neurology·J J Gilbert, M Sadler
Feb 1, 1983·Neurology·D M KaufmanM H Miller
Mar 1, 1984·Controlled Clinical Trials·C Jennison, B W Turnbull
Feb 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·E J ThompsonP Rudge
Nov 1, 1980·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·G C Ebers, D W Paty
Apr 1, 1982·Neurology·P D MehtaW W Tourtellotte
May 8, 1981·Science·A T HaaseW W Tourtellotte
Jun 1, 1981·Annals of Neurology·W W TourtellotteA R Potvin

❮ Previous
Next ❯

Citations

Oct 26, 2007·Immunologic Research·Sangjin OhHorea Rus
Dec 1, 1988·Journal of Neuroimmunology·C S Raine, L C Scheinberg
Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Robert A Bermel, Richard A Rudick
Aug 14, 1999·Immunology·J C EdwardsV M Abrahams
Aug 1, 1986·The Journal of Clinical Investigation·M B BaniaB G Arnason
Feb 19, 2008·CNS Drugs·Jorge CorrealeWendy Gilmore
Dec 1, 1990·Molecular and Chemical Neuropathology·N MiyataniR K Yu
Apr 1, 1991·Journal of Neurology·H MitsumotoM Solimena
Jan 1, 1991·Critical Reviews in Clinical Laboratory Sciences·P D Mehta
Jan 1, 1988·Annals of the New York Academy of Sciences·H F McFarland
Feb 1, 1990·Acta Neurologica Scandinavica·A WallinL Svennerholm
May 1, 1990·Annals of Clinical Biochemistry·S RatnaikeD Deam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.